196 related articles for article (PubMed ID: 16761500)
1. Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients.
Wozniacka A; Lesiak A; Narbutt J; McCauliffe DP; Sysa-Jedrzejowska A
Lupus; 2006; 15(5):268-75. PubMed ID: 16761500
[TBL] [Abstract][Full Text] [Related]
2. The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus.
Wozniacka A; Lesiak A; Boncela J; Smolarczyk K; McCauliffe DP; Sysa-Jedrzejowska A
Br J Dermatol; 2008 Nov; 159(5):1124-30. PubMed ID: 18764842
[TBL] [Abstract][Full Text] [Related]
3. Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.
Lesiak A; Narbutt J; Sysa-Jedrzejowska A; Lukamowicz J; McCauliffe DP; Wózniacka A
Lupus; 2010 May; 19(6):683-8. PubMed ID: 20064914
[TBL] [Abstract][Full Text] [Related]
4. [Proinflammatory cytokines in inactive lupus erythematosus patients].
Lesiak A; Sysa-Jedrzejowska A; Narbutt J; Lukamowicz J; Robak E; Wozniacka A
Przegl Lek; 2005; 62(9):838-42. PubMed ID: 16541713
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cytokine kinetics to single bouts of acute moderate and intense aerobic exercise in women with active and inactive systemic lupus erythematosus.
Perandini LA; Sales-de-Oliveira D; Mello S; Camara NO; Benatti FB; Lima FR; Borba E; Bonfa E; Roschel H; Sá-Pinto AL; Gualano B
Exerc Immunol Rev; 2015; 21():174-85. PubMed ID: 25825870
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine treatment reduces the number of cutaneous HLA-DR+ and CD1a+ cells in patients with systemic lupus erythematosus.
Wozniacka A; Lesiak A; Narbutt J; Kobos J; Pavel S; Sysa-Jedrzejowska A
Lupus; 2007; 16(2):89-94. PubMed ID: 17402364
[TBL] [Abstract][Full Text] [Related]
7. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients.
McCarthy EM; Smith S; Lee RZ; Cunnane G; Doran MF; Donnelly S; Howard D; O'Connell P; Kearns G; Ní Gabhann J; Jefferies CA
Rheumatology (Oxford); 2014 Sep; 53(9):1586-94. PubMed ID: 24706988
[TBL] [Abstract][Full Text] [Related]
8. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
López P; Gómez J; Prado C; Gutiérrez C; Suárez A
J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
[TBL] [Abstract][Full Text] [Related]
9. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
Meinão IM; Sato EI; Andrade LE; Ferraz MB; Atra E
Lupus; 1996 Jun; 5(3):237-41. PubMed ID: 8803897
[TBL] [Abstract][Full Text] [Related]
10. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus.
Postal M; Peliçari KO; Sinicato NA; Marini R; Costallat LT; Appenzeller S
Cytokine; 2013 Mar; 61(3):785-91. PubMed ID: 23332615
[TBL] [Abstract][Full Text] [Related]
11. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
[TBL] [Abstract][Full Text] [Related]
12. Decrease in circulating DNA, IL-10 and BAFF levels in newly-diagnosed SLE patients after corticosteroid and chloroquine treatment.
Cepika AM; Soldo Jureša D; Morović Vergles J; Malenica B; Santak M; Kapitanović S; Mayer M; Anić B; Sentić M; Gagro A
Cell Immunol; 2012; 276(1-2):196-203. PubMed ID: 22703694
[TBL] [Abstract][Full Text] [Related]
13. Antimalarials and cholesterol profile of patients with systemic lupus erythematosus.
Rossoni C; Bisi MC; Keiserman MW; Staub HL
Rev Bras Reumatol; 2011; 51(4):383-4, 386-7. PubMed ID: 21779713
[TBL] [Abstract][Full Text] [Related]
14. Cytokine production, serum levels and disease activity in systemic lupus erythematosus.
Gröndal G; Gunnarsson I; Rönnelid J; Rogberg S; Klareskog L; Lundberg I
Clin Exp Rheumatol; 2000; 18(5):565-70. PubMed ID: 11072595
[TBL] [Abstract][Full Text] [Related]
15. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
16. Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.
Umare V; Pradhan V; Nadkar M; Rajadhyaksha A; Patwardhan M; Ghosh KK; Nadkarni AH
Mediators Inflamm; 2014; 2014():385297. PubMed ID: 25548434
[TBL] [Abstract][Full Text] [Related]
17. Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus--a case report.
Bogaczewicz J; Sobów T; Bogaczewicz A; Robak E; Bienkowski P; Sysa-Jedrzejowska A; Wozniacka A
Lupus; 2014 Feb; 23(2):188-93. PubMed ID: 24297641
[TBL] [Abstract][Full Text] [Related]
18. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines.
Amerio P; Frezzolini A; Abeni D; Teofoli P; Girardelli CR; De Pità O; Puddu P
Clin Exp Rheumatol; 2002; 20(4):535-8. PubMed ID: 12175109
[TBL] [Abstract][Full Text] [Related]
19. Cytokine panel and histopathological aspects in the systemic lupus erythematosus.
Avrămescu C; Biciuşcă V; Dăianu T; Turculeanu A; Bălăşoiu M; Popescu SN; Ionete O; Simionescu C
Rom J Morphol Embryol; 2010; 51(4):633-40. PubMed ID: 21103619
[TBL] [Abstract][Full Text] [Related]
20. Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs.
López P; Gómez J; Mozo L; Gutiérrez C; Suárez A
Arthritis Res Ther; 2006; 8(2):R42. PubMed ID: 16507146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
